<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Eur J Nucl Med Mol Imaging</journal-id>
      <journal-title-group>
        <journal-title>European Journal of Nuclear Medicine and Molecular Imaging</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1619-7070</issn>
      <issn pub-type="epub">1619-7089</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20016891</article-id>
      <article-id pub-id-type="pmc">2822228</article-id>
      <article-id pub-id-type="publisher-id">1329</article-id>
      <article-id pub-id-type="doi">10.1007/s00259-009-1329-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Image of the Month</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Active inflammation in <sup>18</sup>F-methylcholine PET/CT</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Le</surname>
            <given-names>Chau</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van de Weijer</surname>
            <given-names>Erik P.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pos</surname>
            <given-names>Floris J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Vogel</surname>
            <given-names>Wouter V.</given-names>
          </name>
          <address>
            <phone>+31-20-5122267</phone>
            <fax>+31-20-5122290</fax>
            <email>w.vogel@nki.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Nuclear Medicine, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands </aff>
        <aff id="Aff2"><label>2</label>Department of Urology, Spaarneziekenhuis, Hoofddorp, The Netherlands </aff>
        <aff id="Aff3"><label>3</label>Department of Radiation Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>12</month>
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>17</day>
        <month>12</month>
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2010</year>
      </pub-date>
      <volume>37</volume>
      <issue>3</issue>
      <fpage>654</fpage>
      <lpage>655</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>10</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>11</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2009</copyright-statement>
      </permissions>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2010</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p><sup>18</sup>F-Methylcholine (FCH) is a marker of proliferation that can be used for the detection and (re)staging of prostate cancer [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. A 78-year-old male with T3G3 prostate cancer (PSA 47&#xA0;&#x3BC;g/l, nadir PSA 2.2&#xA0;&#x3BC;g/l with LHRH treatment) and rising PSA (4.8&#xA0;&#x3BC;g/l) was referred for restaging with FCH PET/CT. Images obtained 30&#xA0;minutes after injection (<bold>a</bold>, <bold>b</bold>) demonstrated choline-avid nodal metastases in the left parailiac and paraaortal regions (<italic>blue arrowheads</italic>). In addition, the upper lobe of the right lung showed diffuse FCH uptake with SUV<sub>mean</sub> 3.0 (<italic>red arrowheads</italic>) and diffuse infiltration on low-dose CT (<bold>c</bold>). Several enlarged mediastinal lymph nodes showed uptake as well (<italic>green arrowheads</italic>). Pulmonary infection with reactive nodes was suspected, but we were unable to discriminate them from mediastinal prostate cancer metastases.
<graphic position="anchor" xlink:href="259_2009_1329_Figa_HTML" id="MO1"/></p>
    <p>In retrospect, the patient had been coughing for several weeks but had no other symptoms. Bronchial lavage revealed legionellosis. After 3&#xA0;weeks treatment with ciprofloxacin the pulmonary infiltration had disappeared completely on the CT scan (<bold>d</bold>), confirming the inflammatory origin of the choline uptake. However, the enlarged mediastinal lymph nodes persisted. No further investigations of the mediastinum were performed because of the age and prognosis of the patient, and the origin of the enlarged nodes remained uncertain.</p>
    <p>As previously suggested by animal experiments [<xref ref-type="bibr" rid="CR3">3</xref>], active infection can be choline-avid. Our case demonstrates that this can even occur in a diffuse and clinically indolent infection. We conclude that, as in FDG PET imaging, when active infection is suspected, adequate antimicrobial treatment should precede FCH PET/CT to avoid compromised imaging of oncological disease.</p>
  </body>
  <back>
    <ack>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Igerc</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kohlf&#xFC;rst</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gallowitsch</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Matschnig</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kresnik</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gomez-Segovia</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localization of prostate cancer</article-title>
          <source>Eur J Nucl Med Mol Imaging</source>
          <year>2008</year>
          <volume>35</volume>
          <fpage>976</fpage>
          <lpage>983</lpage>
          <pub-id pub-id-type="doi">10.1007/s00259-007-0686-9</pub-id>
          <pub-id pub-id-type="pmid">18188560</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heinisch</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dirisamer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Loidl</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Stoiber</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gruy</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Haim</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA&#x2009;&lt;&#x2009;5&#xA0;ng/ml?</article-title>
          <source>Mol Imaging Biol</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>43</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="doi">10.1007/s11307-005-0023-2</pub-id>
          <pub-id pub-id-type="pmid">16315004</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wyss</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Honer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sp&#xE4;th</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ametamey</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Westera</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET</article-title>
          <source>Eur J Nucl Med Mol Imaging</source>
          <year>2004</year>
          <volume>31</volume>
          <fpage>312</fpage>
          <lpage>316</lpage>
          <pub-id pub-id-type="doi">10.1007/s00259-003-1337-4</pub-id>
          <pub-id pub-id-type="pmid">14628099</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
